Altering certain molecular interactions could yield new strategies for treating prostate cancer

Reviewed Research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered that altering certain molecular interactions could yield new strategies for treating prostate cancer and related diseases. The study focuses on androgen receptors (AR), which are protein molecules that help direct the development of male sexual characteristics, […]

Continue reading »

Doctor issues ‘vital’ advice on whether its safe to take paracetamol every day

Pharmacist explains how paracetamol and ibuprofen work Whether you use it to target a stubborn headache or to relieve various aches and pains, paracetamol is the go-to painkiller for many. And while paracetamol is one of the safest painkillers out there, the popular medication can also trigger side effects in some cases, just like any other medicine. Fortunately, the small pill “rarely” […]

Continue reading »

Antidepressants versus running for depression: Is there a winner?

The first study to compare effects of antidepressants with running exercises for anxiety, depression and overall health shows that they have about the same benefits for mental health—but a 16-week course of running over the same period scores higher in terms of physical health improvement, whereas antidepressants lead to a slightly worse physical condition, as has been suggested by previous […]

Continue reading »

Tech Improves Glycemic Outcomes in Type 1 Diabetes Pregnancy

HAMBURG, Germany — Hybrid closed-loop therapy significantly improved maternal glycemic control during pregnancy in people with type 1 diabetes, providing a clinical advantage beyond that achieved with continuous glucose monitoring (CGM) and insulin-pump therapy, shows the AiDAPT randomized controlled trial. The results were presented for the first time at this year’s European Association for the Study of Diabetes (EASD) meeting […]

Continue reading »

Healthcare generative AI predicted to reach $22B by 2032

The Generative AI Tracker said this week the healthcare generative artificial intelligence market is valued at more than $1 billion as of 2022, but technology companies and investors will play a significant role in development. They’ll team up with healthcare companies including providers, payers and others in the healthcare ecosystem to train large language models on healthcare-specific data and establish […]

Continue reading »

Adverse Events Compared for Gout Flare Prophylactic Drugs

TOPLINE: Matched cohort studies revealed infrequent adverse events (AEs) with either treatment, but the number needed to harm for any AE was more than three times higher with colchicine vs NSAIDs. METHODOLOGY: The researchers conducted two matched retrospective cohort studies using the UK Clinical Practice Research Datalink and the Hospital Episode Statistics primary care datasets to compare AEs in adults […]

Continue reading »

Advanced Alzheimer's: Bryostatin-1 may be safe, effective

Synaptogenix, an emerging biopharmaceutical company working on treatments for brain-related disorders, recently shared findings from their Phase 2 trial on a drug called Bryostatin-1 for Alzheimer’s disease. The results of a recent phase 2 clinical trial indicate that Bryostatin-1 may halt cognitive decline in patients with severe Alzheimer’s, in contrast to placebo recipients who demonstrated a drop in cognitive function. […]

Continue reading »

Why are most Americans skipping the COVID-19 booster?

In a recent study published in the journal Vaccine, researchers investigated why more than 80% of eligible Americans have not taken their severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) vaccine booster dose. They conducted an online survey of 2,298 respondents to evaluate the reasons underlying the low observed response. Their results elucidate that, despite consistent research and clinical reports depicting […]

Continue reading »
1 37 38 39 40 41 1,322